Specify a stock or a cryptocurrency in the search bar to get a summary
ASKA Pharmaceutical Holdings Co Ltd
4886ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan. Address: 5-1, Shibaura 2-Chome, Tokyo, Japan, 108-8532
Analytics
WallStreet Target Price
380 683.76 JPYP/E ratio
10.0598Dividend Yield
2.31 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4886
Dividend Analytics 4886
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
12 %Dividend History 4886
Stock Valuation 4886
Financials 4886
Results | 2019 | Dynamics |